BIO Deutschland takes part in the Analytica

Panel discussion “IPO – Where to Go?” (from left to right: Alexandre L. Ibrahim, Head of International Capital Markets at the New York Stock Exchange; Florian Fischer, CFO of Affimed N.V.; Siegfried Bialojan, Executive Director and Head of Life Science Center at Ernst & Young GmbH, Wirtschaftsprüfungsgesellschaft; Isabella Schidrich, Senior Managing Director at NASDAQ OMX; Oliver Schacht, CEO of Curetis AG and board member of BIO Deutschland; Jürgen Eck, CEO of brain AG. © GoingPublic

The Analytica trade show was held in Munich from 10 to 13 May. BIO Deutschland participated with a booth in the Biotech Forum. Here Finance Day and the Personalized Medicine Focus Day took place on 12 and 13 May respectively. Both events were organised by GoingPublic Media AG. The talks and panel discussions, which drew a total of nearly 500 interested attendees, sparked many lively exchanges.

Viola Bronsema, Managing Director of BIO Deutschland, opened Finance Day with a talk about the importance of the public’s perception of the biotech sector and the significance of communications.

Among the participants of the panel discussion “IPO – Where to Go?” was Oliver Schacht, board member of BIO Deutschland, who took his diagnostics firm Curetis public in November of last year.

Martin Pöhlchen, Managing Director of Sinfonie LSM GmbH and chairman of BIO Deutschland’s Working Group on Bio IT and Big Data, gave a talk on “Big Data in Personalized Medicine – Opportunities and Challenges” as part of the Personalized Medicine Focus Day, and took part in the podium discussion “Volume, Velocity and Variety – from Big to Smart Data”.

Some 35,000 industry professionals learned about the latest trends and developments in laboratory technology, analysis and biotechnology. A total of 1,244 exhibitors presented their products and services in five halls of the Messe München exhibition centre. As in previous years, Hall A3 was devoted to biotechnology, diagnostics and the life sciences. Here the nearly 320 companies and the several live labs and forums were delighted with the keen interest shown by the professional attendees.


Go back